Our latest article “Strict Procedures vs Urgent Needs: Is it possible to be equal to the occasion?” by Nihan Bacanak, Can Aksoy ve Bengüsu Güvendi is published on Lexology.
As known, pharmaceutical products for human use can in principle only be placed on the market upon obtaining a licence for the specified indications for which the product is allowed to be used. On the other hand, as experienced during the COVID-19 pandemic, not being able to access pharmaceutical products particularly in cases of emergency where a licensed product is unavailable can lead to aggrievements and the lengthiness of the process of obtaining a licence for a pharmaceutical product can cause additional problems. Hence it is of utmost importance to properly set a balance between satisfying the urgent needs of patients in an efficient manner and safely placing the products on the market. Various methods enabling patients to access unlicensed products are available under Turkish law. Amongst these methods which are briefly described below, named patient programme and off-label use have enabled rapid actions to be taken in particular during the COVID-19 pandemic.
You may reach the article here.
Share
Related persons
You can contact us for detailed information.

Legal Information
This briefing is for information purposes; it is not legal advice. If you have questions, please call us. All rights reserved.
You May Be Interested In
2 March 2026
Use of Health Declarations in Cosmetic Products
A health declaration is any statement or implication that a product or ingredients within its composition confers a benefit on human health…
19 February 2026
Turkish Competition Law Newsletter – 2026 Winter Issue
Welcome to the 2026 Winter edition of the Paksoy Turkish Competition Law Newsletter series.
17 February 2026
The Constitutional Court Confirmed the Competition Authority’s Power to Conduct On-Site Inspections
The Constitutional Court decision dated 6 November 2025 and numbered E. 2023/174, K. 2025/224 (“Constitutional Court Decision”), published…
17 February 2026
Türkiye’s Digital Copyright Bill under parliamentary review: key takeaways for digital platforms and rightsholders
On 10 December 2025, the Digital Copyright Bill (“Bill”) was submitted to the Presidency of the Turkish Parliament.
11 February 2026
New Merger Control Regulation From The Turkish Competition Board: Increased Turnover Thresholds And Special Regulation For Technology Undertakings
With the Communiqué Amending the Communiqué on Mergers and Acquisitions Requiring the Approval of the Competition Board (Communiqué No:…
6 February 2026
Legal Developments Regarding the Cultivation of Cannabis and Cannabis Products
The Regulation on Cannabis Cultivation and Control (“Regulation on Cannabis Cultivation”) and the Regulation on Products Derived from…